Research Article

ACEI and ARB Lower the Incidence of End-Stage Renal Disease among Patients with Diabetic Nephropathy: A Meta-analysis

Figure 2

Forest diagram of the effect of RAS blocker and placebo on the incidence of end-stage renal disease.